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Background: Malignant  phylliodes tumour (MPT) is a rare breast tumor. Surgery is 
the mainstay in treatment but varies from local resection to modified radical 
mastectomy. In this study, we present our experience using wide local excision or 
subcutaneous mastectomy and immediate breast reconstruction in the management of 
MPT.
Methods and Results: Twenty-three recurrent MPT and ten patients with histological evidence of 
MPT were included. All patients with recurrent MPT (n=23) had subcutaneous mastectomy, tow 
centimeter wide excision of the scar and immediate breast reconstruction with either Latissimus Dorsi 
(LD) myocutaneous flap (n= 10) or Latissimus Dorsi muscle flap (n=13). Seven of the newly diagnosed 
patients had wide local excision of the tumor, reconstruction with LD muscle flap, tow had wide local 
excision and reduction of contra lateral breast, and one had subcutaneous mastectomy and silicon 
implant. The margin resection varied between five and fifteen centimeter in wide local resection group 
and subcutaneous mastectomy group respectively and the size of tumors varied between five and fifteen 
centimeters in diameter.
Discussion: During the follow up period, which ranged between twenty-four and eighty-four months 
one local recurrence, was recorded (3.03%) and none of the patients had distant metastasis or regional 
lymph nodes involvement. This approach has secured wider excision of MPT, offered breast 
reconstruction, and has reduced the chances of recurrence in our patients. 
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ystosarcoma phylliodes   constitutes 0.3-
0.9% of all breast tumors, the term 
"sarcoma" was initially used because of its 
fleshy appearance; a more modern term is 
Phylliodes tumour (PT). The behavior of PT 
constitutes a spectrum from benign and locally 
recurrent to malignant and metastatic. Other 
classifications have also been suggested
1-3
. 
Malignancy is determined by characteristics of 
the stroma. MPT constitutes between 6% and 
30% of all PT
4-10
.                                                                                   
Malignant  change of the epithelium in PT  is a 
rare occurrence, the most frequent is  infiltrating 
carcinoma of various types but  lobular 
carcinoma in situ and  ductal carcinoma in situ 
are  much rarer and  adenocarcinoma may also  
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The metastatic spread of MPT is mainly 
haematogenous to the lungs while lymphatic 
involvement is infrequent
2
. Metastasis to the 
interpectoral lymph node (Rotter's) was reported 
first in Japan
14




 The surgical management of MPT varies widely.  
Wide local excision (WLE) (at least 2 cm of 
histologically normal breast tissue margin and/or 
a clearly defined fascial boundary) remains the 
treatment of choice. Radical or modified radical 
mastectomy have been reported as an appropriate 
procedure in selected patients
2,15
. As lymph node 
metastases is rare occurrence, axillary dissection 
is not recommended in the absence of 
adenocarcinoma elements   and in deep seated 
lesions excision must include fascia
2,15
. Although 
mastectomy is the treatment of choice in specific 
cases, sacrifice of the adolescent breast at the 
initial procedure was strongly discouraged. Hence 
preoperative diagnosis is important in planning 
the most appropriate type of surgery 
16,17
.                                  
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Breast conserving surgery, subcutaneous 
mastectomy and breast implants in management 
of MPT have been reported, and autologous 
tissue breast reconstruction following excision of 
MPT was also used
18-26
.    
Although there is no known role for 
chemotherapy in the adjuvant setting, 
radiotherapy may be useful in selected cases
5,17
.                                                           
Recurrence rates following local excision of MPT 
ranges between 6% and 40%
5,7,8
  and it  may 
indicate  development of metastases even in 
patients with "benign" disease). Recurrence 
following local and wide local excision was 
reported to happen between 5 and 237 months 
from the primary treatment and it was suggested 





This study was carried out between June1998 and 
June2005. Twenty three consecutive patients with 
recurrent PT and 10 new patients with cytological 
and / or histological proof of MPT were enrolled.                                                                      
Two of the new patients had bilateral breast 
hypertrophy; these had wide local excision of the 
tumor via reduction mammoplasty pattern and 
had reduction of the contra lateral breast. Seven 
had wide local excision and immediate 
reconstruction using Latisimus Dorsi (LD) 
muscle flap and one had subcutaneous 
mastectomy and silicon implant.                            
All patients with recurrent PT had subcutaneous 
mastectomy, two-centimeter margin excision of 
the previous scar and all had immediate breast 
reconstruction with LD. 
Patients were followed up over a period of 
sixteen to eighty eight months. The data of all 
patients were entered and analyzed using Excel 
computer program. 
Results:
Types of operation for all the patients were show 
in table1. The ages of patients ranged from 15 to
40 with a mean of 24.06 years.  93% of the 
patients were less than 30 years old (table 2). Out 
of the twenty three patients with recurrent disease 
two had second recurrence and their histology 
revealed MPT. However, in nine of them the 
original tumour was benign PT. The time 
between primary surgery and recurrence ranged 
between five and twenty three months. In patients 
with recurrent disease the previous local excision 
was for  what was thought  clinically to be 
fibroadenoma (n =9),  giant fibroadenoma (n=6) 
and  histologically proven MPT(n=8).  Of the 
patients presenting for the first time (n = 10), 
seven had cytological evidence of MPT, three had 
histological evidence of MPT and one of them 
had co-existing ductal carcinoma in situ.                        











       Table 2  Age Distribution of patients
Age %
15-20 years 21 %
21-30 years 72%
31-40 years 7%
    Of the twenty-three patients with recurrent 
tumors who had subcutaneous mastectomy and 
wide scar excision, ten were reconstructed with 
LD myocutaneous flap (Fig1) and thirteen with 
muscle only (Fig 2). 
A                                    B
Figure 1A show a patient presenting with 
recurrent MPT following local excision (Supra-
areolar). Figure 1B shows the same patient 
following wide excision of the scar, subcutaneous 
mastectomy and breast reconstruction with LD 
myocutaneous flap.
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Figure 2 shows a patient with recurrent MPT of 
right breast (Left). The picture on the right shows 
the same patient following subcutaneous 
mastectomy and LD myocutaneous flap 
reconstruction of the breast.
The remaining ten patients who presented for the 
first time with breast lump, seven had wide local 
excision and LD muscle reconstruction to correct 
the deformity, two had reduction mammoplasty 
pattern wide excision  (fig 3A & B) and one had 
subcutaneous mastectomy and silicon implant as 
the tumor was occupying most of the breast
3A                                     B
Figures 3A and 3B Shows a patient with MPT 
before and after reduction mammoplasty pattern 
wide excision.
The size of the tumors ranged from five to fifteen 
centimeter in diameter and the resection margin 
ranged from five centimeters in the wide local 
excision group to twelve centimeter in patients 
who had subcutaneous mastectomy (mean 7.9 
centimeter). 
During the period of the follow up, which ranged 
between twenty- two and twenty- four months, 
local recurrence was detected in one patient who 
presented originally with recurrent disease 
(3.03%). None of the patients developed distant 
metastasis or regional lymphadenopathy.
Discussion:
  MPT is rare and surgery is the mainstay of its 
management. Breast conserving and local 
excision have been widely practiced and the 
recurrence reported in the literature following 
local excision in MPT was up to 40%. It has also 
been suggested   that free- resection margin 
reduces chances of recurrence and positive 
resection margins are associated with higher 
chances of local recurrence
5,7,8,26,30,31
. 
Mastectomy on one hand has been discouraged in 
young patients and sacrifice of nipple/areola 
complex and skin envelope on the other hand is 
not relevant in this condition especially in young 
patients and adequate resection is the most
important factor in controlling this disease
2, 5, 15,16, 
26
.                                                                                           
In this study, the ages of patients have ranged 
between 15 and 40 years with an average of 24.06 
years (Table 2). This is strikingly different from 
the literature where the average age ranged 
between 38 and 52 years
5,7- 9,28, 32
.This is difficult 
to explain but it makes mastectomy a more 
difficult option in younger population of patients . 
In this study 23 patients (75 %) had recurrent 
disease, this was attributed to the diagnosis of 
fibroadenoma in 15 and to local excision of 
phylloides tumor in the rest .This matches the 
explanation reported in the literature and stresses 
the difficulty in differentiation of PT from 
fibroadenoma
5,33
.                                                                                                     
All patients with recurrent MPT had 
subcutaneous mastectomy and wide excision of 
the previous scar and all new patients with MPT 
had wide local excision up to quadrantectomy 
depending on the size of the tumor in relation to 
the breast size.  Resection margins have ranged 
between five and 12 centimeter   and none of the
tumors was incompletely excised.
 Immediate reconstruction of the breast was 
performed in thirty patients using LD flap and 
silicon implant in one and two patients had 
reduction mammoplasty pattern wide resection of 
the tumor. 
The literature on subcutaneous mastectomy and 
breast reconstruction in the management of PT is 
scarce, few papers have been published 
addressing a small number of patients and to our 




 The accessibility and reliability of LD flap in 
breast reconstruction in general and in PT are 
well documented in the literature and cannot be 
stressed any more
20
. In this study, although the 
number of patients is small, no distant metastasis 
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was have encountered during the follow up 
period and local recurrence was seen in only one 
(3.03%) patient who had subcutaneous 
mastectomy for recurrent MPT. This is much less 
when compared with the reports in the literature 
where recurrence ranged between 6% and 40 % 
following local and wide local excision but there 
are few reports on immediate breast 
reconstruction following excision of MPT
5-7, 26-28, 
32
.    
 Excision and immediate reconstruction in 
management of MPT allows wider clearance as 
deformity is no longer a concern. It was 
suggested that this approach in the management 
of MPT offers wider excision, reduces chances of 
recurrence, offers reconstruction and protects 
patients from psychosexual disturbances associate 
with mastectomy. 
Long-term follow up of this approach in young 
patients will declare its effectiveness in 
management of MPT. 
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